Jefferies Raising Price Target On LCA-Vision, Inc. (NASDAQ: LCAV)

Jefferies & Co. is raising its price target on shares of LCA-Vision, Inc. LCAV to $7 from $5, but is keeping its Hold rating on shares. In a note to investors, Jefferies writes, "We continue to view shares of LCAV as a late cycle recovery play that could yield attractive returns for high risk tolerant investors over the medium-term. However, given the absence of a sustained uptrend in procedure volumes and ongoing losses, we remain sidelined." Shares of LCAV are trading at $7.42 in early Thursday trading.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorPrice TargetAnalyst RatingsHealth CareHealth Care FacilitiesJefferies & Co.
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!